Alpha Thalassemia Panel
Use
This test is intended for individuals with clinical or suspected diagnosis of alpha thalassemia, those with laboratory results consistent with HbH or Hb Bart patterns, and reproductive partners of individuals with a known pathogenic variant in the HBA1 or HBA2 genes. It aims to confirm diagnosis and aid in genetic counseling for affected families.
Special Instructions
New York approved. A STAT testing option is available for expedited results, which adds a 25% surcharge unless the report is late.
Limitations
This analysis will not detect all possible genetic variations associated with alpha thalassemia, as it is limited to the genes and methodologies included in this test. Results should be interpreted in the context of clinical findings and other diagnostic results.
New York Approved
Methodology
Other
Biomarkers
Result Turnaround Time
12-19 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided